Introduction
With the increase in survival as a result of cyclophosphamide therapy, new complications of Wegener's granulomatosis have been encountered. TheEe include the adverse effects of treatment, bacterial infections of the nose and paranasal sinuses (Fauci and Wolff, 1973) , obstructive laryngitis (personal observation) and subacute or chronic endobronchial disease which may lead to progressive narrowing and stenosis (Flye, Mundinger and Fauci, 1979 (Fig. 1) . Since then, several sputum cultures have yielded Aspergillus, and serum precipitins, which were formerly negative for this pathogen, have become positive, and the patient has experienced recurrent, though not life-threatening, haemoptysis. On the other hand, a complete remission of the Wegener's granulomatosis is maintained, even though the corticosteroids have been withdrawn and cyclophosphamide reduced to 50 mg/day. However, only partial resolution of the pulmonary infiltrate has been achieved, apparently because of the presence of the aspergilloma.
Discussion
Pulmonary aspergillomas have been identified in association with a wide variety of lung diseases, including tuberculosis, sarcoidosis, asbestosis, histoplasmosis, ankylosing spondylitis, bronchiectasis, bronchial cysts and malignancy. The presence of a pre-existing lung cavity appears to be the most common predisposing factor to the formation of an aspergilloma (Pennington, 1980) . In Wegener's granulomatosis, excavation of the lung infiltrates occurs in roughly 50% of cases (Fauci and Wolff, 1973 
